Perigon Wealth Management, LLC Abb Vie Inc. Transaction History

Perigon Wealth Management, LLC

$3.42 Billion
Q2 2024

A detailed history of Perigon Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Perigon Wealth Management, LLC holds 93,432 shares of ABBV stock, worth $18.2 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

93,432

Previous 97,029 3.71%

Holding current value

$18.2 Million

Previous $17.7 Million 9.3%

% of portfolio

0.47%

Previous 0.54%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$154.79 - $180.76 $556,779 - $650,193	-3,597 Reduced 3.71%	93,432 $16 Million
Q1 2024 Apr 29, 2024	SELL	$159.82 - $182.1 $904,581 - $1.03 Million	-5,660 Reduced 5.51%	97,029 $17.7 Million
Q4 2023 Jan 29, 2024	BUY	$137.6 - $154.97 $2.07 Million - $2.33 Million	15,053 Added 17.18%	102,689 $15.9 Million
Q3 2023 Oct 30, 2023	BUY	$133.59 - $154.65 $203,323 - $235,377	1,522 Added 1.77%	87,636 $13.1 Million
Q2 2023 Aug 02, 2023	BUY	$132.51 - $164.9 $6.09 Million - $7.58 Million	45,977 Added 114.55%	86,114 $11.6 Million
Q1 2023 May 03, 2023	BUY	$144.61 - $166.54 $35,863 - $41,301	248 Added 0.62%	40,137 $6.4 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $1.27 Million - $1.53 Million	9,210 Added 30.02%	39,889 $6.45 Million
Q3 2022 Dec 13, 2022	BUY	$134.21 - $153.93 $592,134 - $679,139	4,412 Added 16.8%	30,679 $4.12 Million
Q2 2022 Aug 11, 2022	BUY	$137.62 - $174.96 $110,646 - $140,667	804 Added 3.16%	26,267 $4.02 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $386,833 - $479,951	2,931 Added 13.01%	25,463 $4.13 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $227,859 - $288,307	2,121 Added 10.39%	22,532 $3.05 Million
Q3 2021 Nov 01, 2021	BUY	$106.4 - $120.78 $2.17 Million - $2.47 Million	20,411 New	20,411 $2.2 Million
Q3 2021 Oct 25, 2021	SELL	$106.4 - $120.78 $2.16 Million - $2.45 Million	-20,322 Closed	0 $0
Q2 2021 Jul 19, 2021	BUY	$105.21 - $117.21 $70,175 - $78,179	667 Added 3.39%	20,322 $2.29 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $235,290 - $259,026	2,300 Added 13.25%	19,655 $2.13 Million
Q4 2020 Jan 28, 2021	SELL	$80.49 - $108.67 $167,499 - $226,142	-2,081 Reduced 10.71%	17,355 $1.86 Million
Q3 2020 Nov 03, 2020	SELL	$85.91 - $100.83 $12,714 - $14,922	-148 Reduced 0.76%	19,436 $1.7 Million
Q2 2020 Jul 29, 2020	BUY	$73.37 - $98.18 $285,776 - $382,411	3,895 Added 24.83%	19,584 $1.92 Million
Q1 2020 Apr 17, 2020	BUY	$64.5 - $97.79 $137,772 - $208,879	2,136 Added 15.76%	15,689 $1.25 Million
Q4 2019 Jan 13, 2020	BUY	$72.13 - $90.25 $20,845 - $26,082	289 Added 2.18%	13,553 $1.21 Million
Q3 2019 Oct 25, 2019	BUY	$62.98 - $75.72 $4,219 - $5,073	67 Added 0.51%	13,264 $988,000
Q2 2019 Aug 05, 2019	SELL	$65.7 - $83.98 $6,241 - $7,978	-95 Reduced 0.71%	13,197 $960,000
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $462 - $544	6 Added 0.05%	13,292 $1.07 Million
Q4 2018 Feb 11, 2019	SELL	$77.85 - $96.01 $2,257 - $2,784	-29 Reduced 0.22%	13,286 $1.09 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $142,256 - $158,144	1,600 Added 13.66%	13,315 $1.26 Million
Q2 2018 Aug 09, 2018	SELL	$89.78 - $106.23 $19,302 - $22,839	-215 Reduced 1.8%	11,715 $1.09 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $644 - $862	7 Added 0.06%	11,930 $1.13 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $8,956 - $9,821	100 Added 0.85%	11,923 $1.15 Million
Q3 2017 Dec 05, 2017	SELL	$69.85 - $89.22 $33,877 - $43,271	-485 Reduced 3.94%	11,823 $1.05 Million
Q2 2017 Sep 12, 2017	BUY	N/A	12,308 New	12,308 $892,000
Q3 2011 Nov 14, 2022	BUY	N/A	4,412	30,679 $4.12 Million

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perigon Wealth Management, LLC with notifications on news.

Account

Perigon Wealth Management, LLC Abb Vie Inc. Transaction History